Ispire Technology, Inc. (ISPR)
NASDAQ:ISPR
Top Page
Ispire Technology, Inc.
(NASDAQ:ISPR)
Select Model
Select Model
Rating:42Neutral
Price Target:
$2.00
▲(2.04% Upside)
Action:ReiteratedDate:03/19/26
ISPR scores low primarily due to weak financial performance (declining TTM revenue, large losses, negative free cash flow, and negative equity). Technicals add pressure with price below key moving averages and a negative MACD. The earnings call provides a partial offset with signs of operational improvement (collections and cost control) and stated improvement guidance, but near-term revenue declines, cash drawdown, and regulatory/execution risks keep the overall score subdued.
Positive Factors
Improved receivables and collections
Material improvement in receivables and cash collection tightens the company’s cash conversion cycle, lowering near-term financing needs. Better collections reduce working-capital strain, increase liquidity optionality, and make operating performance more resilient while management executes its customer-quality pivot.
Negative Factors
Sharp revenue decline
A >50% year-over-year revenue drop erodes scale benefits and strains margin absorption. The decline reflects deliberate customer exits and weaker demand, reducing recurring cash inflows and making recovery dependent on successful execution of new product rollouts and partner ramps over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved receivables and collections
Material improvement in receivables and cash collection tightens the company’s cash conversion cycle, lowering near-term financing needs. Better collections reduce working-capital strain, increase liquidity optionality, and make operating performance more resilient while management executes its customer-quality pivot.
Read all positive factors
Ispire Technology, Inc. (ISPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$104.84M
Dividend YieldN/A
Average Volume (3M)44.30K
Price to Earnings (P/E)―
Beta (1Y)1.02
Revenue Growth-20.13%
EPS Growth-88.66%
CountryUS
Employees98
SectorConsumer Defensive
Sector Strength42
IndustryTobacco
Share Statistics
EPS (TTM)-0.12
Shares Outstanding57,289,864
10 Day Avg. Volume39,789
30 Day Avg. Volume44,298
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)240.69
Price to Sales (P/S)1.14
P/FCF Ratio-17.17
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue0.96
Enterprise Value/Gross Profit5.87
Enterprise Value/Ebitda-9.12
Forecast
1Y Price Target
$6.50Price Target Upside231.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.08
Revenue Forecast (FY)$139.50M
Ispire Technology, Inc. Business Overview & Revenue Model
Company Description
Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited...
How the Company Makes Money
Ispire Technology generates revenue primarily by selling vaping/ENDS hardware and related products. Its revenue model typically includes: (1) consumer-branded device sales, where the company earns revenue from wholesale distribution of its own bra...
Ispire Technology, Inc. Key Performance Indicators (KPIs)
Ispire Technology, Inc. Earnings Call Summary
Earnings Call Date:Feb 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:May 19, 2026
Earnings Call Sentiment Neutral
The call portrayed a company at an operational inflection point: management highlighted meaningful improvements in collections, expense control, and strategic positioning (age-gating technology, Gmesh, Malaysian capacity) that set the stage for future revenue recovery. However, near-term financials remain challenged — revenue and gross profit were cut roughly in half year-over-year, cash balances declined, and operating cash flow was negative on a six-month basis. The progress on technology partnerships and regulatory engagement is promising but subject to timing and approval risk. Overall, the tone is cautiously optimistic with clear near-term headwinds.Positive Updates
Accounts Receivable and Collections Improvement
Net accounts receivable improved to $37.9M from $47.0M (down ~$9.1M, ~19.4%) and days sales outstanding improved by 8 days. Cash collected versus revenue for calendar year 2025 was 116% versus 67% in 2024 (an increase of 49 percentage points), indicating materially improved collections.
Negative Updates
Sharp Revenue Decline
Total revenue fell to $20.3M from $41.8M year-over-year, a decline of $21.5M (~51.4%), driven by the deliberate exit of lower-value customers and mix shift away from cannabis products.
Read all updates
Q2-2026 Updates
Positive
Negative
Accounts Receivable and Collections Improvement
Net accounts receivable improved to $37.9M from $47.0M (down ~$9.1M, ~19.4%) and days sales outstanding improved by 8 days. Cash collected versus revenue for calendar year 2025 was 116% versus 67% in 2024 (an increase of 49 percentage points), indicating materially improved collections.
Read all positive updates
Company Guidance
Management guided that fiscal 2026 should deliver continued top‑line growth, consistent cash flow and bottom‑line improvement and said the recent trends should continue through the year; key metrics cited include Q2 revenue of $20.3M (vs. $41.8M prior year), gross profit $3.5M (vs. $7.7M) and gross margin 17.1% (vs. 18.5%), operating expenses down to $10.3M (from $15.1M), net loss narrowed to $6.6M (from $8.0M) with a six‑month year‑over‑year net loss improvement of $3.7M, net accounts receivable improved to $37.9M (from $47.0M), cash collected versus revenue 116% for calendar 2025 (vs. 67% in 2024), days‑sales‑outstanding improved by eight days, operating cash burn was only $1.0M from April–Dec 2025, cash on hand $17.6M (vs. $24.4M at 6/30/2025), net cash used in operating activities $5.2M (vs. $0.4M provided prior year six months), investing cash used $0.9M (vs. $1.1M) and financing cash used $0.7M (vs. $0), and management also highlighted operational catalysts including a Malaysian facility expansion from six to 80 production lines and an iQTEC/partner launch initially targeting 2–3M chips/month with a goal of up to 10M devices/month within 12 months.Ispire Technology, Inc. Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.97M | 127.49M | 151.91M | 115.61M | 88.10M | 63.41M |
| Gross Profit | 15.85M | 22.65M | 29.78M | 20.78M | 13.31M | 10.42M |
| EBITDA | -10.20M | -35.76M | -12.18M | -3.40M | -843.13K | 3.96M |
| Net Income | -35.51M | -39.24M | -14.77M | -6.00M | -1.87M | 2.94M |
Balance Sheet | ||||||
| Total Assets | 84.40M | 102.22M | 122.64M | 90.40M | 100.74M | 93.86M |
| Cash, Cash Equivalents and Short-Term Investments | 17.57M | 24.35M | 35.07M | 49.43M | 74.48M | 85.25M |
| Total Debt | 5.68M | 7.06M | 3.40M | 3.91M | 347.54K | 478.11K |
| Total Liabilities | 92.06M | 101.61M | 88.18M | 58.93M | 88.97M | 80.11M |
| Stockholders Equity | -7.66M | 604.69K | 34.46M | 31.47M | 11.77M | 13.76M |
Cash Flow | ||||||
| Free Cash Flow | -25.09M | -8.47M | -21.45M | -8.60M | -7.68M | 5.02M |
| Operating Cash Flow | -24.27M | -7.37M | -18.30M | -7.58M | -7.56M | 5.02M |
| Investing Cash Flow | -5.44M | -5.20M | 2.99M | -10.15M | -121.52K | -798.00 |
| Financing Cash Flow | 3.77M | 1.85M | 10.08M | -16.44M | -3.09M | -227.85K |
Ispire Technology, Inc. Technical Analysis
Negative
1.96
Price Trends
2.42
Negative
2.50
Negative
2.57
Negative
Market Momentum
-0.15
Negative
45.30
Neutral
36.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ISPR, the sentiment is Negative. The current price of 1.96 is above the 20-day moving average (MA) of 1.82, below the 50-day MA of 2.42, and below the 200-day MA of 2.57, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 45.30 is Neutral, neither overbought nor oversold. The STOCH value of 36.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ISPR.
Ispire Technology, Inc. Risk Analysis
Ispire Technology, Inc. disclosed 47 risk factors in its most recent earnings report. Ispire Technology, Inc. reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ispire Technology, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | $1.42B | 34.13 | 20.84% | 0.28% | 6.71% | 8.16% | |
56 Neutral | $1.32B | 9.94 | 5.81% | 6.15% | 3.01% | -7.14% | |
44 Neutral | $1.42M | -0.42 | -133.50% | ― | -34.81% | 99.30% | |
42 Neutral | $104.84M | -6.07 | -2384.12% | ― | -20.13% | -88.66% | |
41 Neutral | $216.57K | -0.10 | -247.42% | ― | -88.85% | 68.28% | |
40 Underperform | $1.49M | >-0.01 | -162.57% | ― | -78.46% | 83.71% |
* Consumer Defensive Sector Average
ISPR
Ispire Technology, Inc.
1.83
-2.24
-55.04%
UVV
Universal
53.10
3.11
6.23%
XXII
22nd Century
2.14
-367.01
-99.42%
TPB
Turning Point Brands
74.29
16.63
28.83%
GNLN
Greenlane Holdings
2.37
-1,689.63
-99.86%
KAVL
Kaival Brands Innovations Group
0.02
-0.46
-96.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.